Key result
Novel EV-D68 lineage drives French outbreak, heavily affecting adults with ~49% of cases.
Why the study?
An early and rapid rise in enterovirus D68 (EV-D68) infections occurred in France in 2024, prompting enhanced nationwide surveillance to characterize the outbreak.
Observational (n=919)
Yes
The 2024 EV-D68 upsurge in France demonstrated early widespread circulation and significant clinical impact on adults, driven by a newly emerged A2-derived lineage.
No takes yet. Share an insight, caveat, or question.
May warrant adult EV-D68 testing in outbreaks; observational data leaves open lineage-specific risks and needs prospective validation.
Jeannoël et al. (2026) conducted an observational in Enterovirus D68 (EV-D68) infection (n=919). Enterovirus D68 (EV-D68) infection was evaluated. During a 2024 upsurge in France, 919 EV-D68 infections were detected, heavily affecting adults (49.1% of cases) and driven by the emergence of a new A2-derived lineage.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: